# Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

> **NCT00480506** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 40 (estimated)

## Conditions studied

- Thalassemia Major

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00480506
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480506, "Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00480506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*